Aier Eye Hospital Group unlocks 6.24m restricted shares for employees

Aier Eye Hospital Group announced the listing and circulation of 6,241,526 restricted shares from the third unlocking period of its 2021 restricted stock incentive plan, effective November 6, 2025. These shares represent 0.0669% of the company's current total share capital. A total of 1,025 incentive recipients have met 100% of the conditions for unblocking these shares.

The unlocked shares are part of a reserved grant initially made on March 25, 2022, with a grant price of 20.71 yuan per share. The third unlocking period covers 25% of the total awarded restricted shares for eligible employees, with the company’s 2024 net profit having grown by 110.96% compared to 2020, exceeding the 80% target.

The company confirmed that all 1,025 incentive recipients met their individual performance assessment requirements. Following this release, the total number of unrestricted tradable shares will increase by 6,241,526, bringing the total to 7,937,200,699 shares, representing 85.11% of the total share capital.